Cargando…
Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review
BACKGROUND: Subcutaneous immunotherapy (SCIT) has been proved to be effective and safe in adult asthma. But it is still controversial in children. OBJECT: To evaluate the efficacy and safety of SCIT in asthmatic children with allergy to house dust mite. METHOD: We searched the databases of Cochrane...
Autores principales: | Zheng, Chen, Xu, Hao, Huang, Shumin, Chen, Zhimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310999/ https://www.ncbi.nlm.nih.gov/pubmed/37397157 http://dx.doi.org/10.3389/fped.2023.1137478 |
Ejemplares similares
-
Effectiveness of sublingual immunotherapy with house dust mite drops in asthmatic children at different ages
por: Ai, Tao, et al.
Publicado: (2023) -
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
por: Yang, Yaqi, et al.
Publicado: (2021) -
Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022) -
Sublingual Immunotherapy for Asthmatic Children Sensitized to House Dust Mite: A Meta-Analysis
por: Liao, Wei, et al.
Publicado: (2015) -
A Study on Late Allergic Reactions to House Dust Mite in Bronchial Asthmatics
por: Kim, You-Young, et al.
Publicado: (1986)